N (%) | P value | |
---|---|---|
Gender | ||
Male | 23 (76.6) | 0.19 |
Female | 7 (23.3) | |
Age (years) | ||
< 45 | 6 (20) | 2.1 |
45–60 | 8 (26.7) | |
> 60 | 16 (53.3) | |
Injection method | ||
Rotisserie group | 3 (20) | 0.6 |
Non-Rotisserie group | 2 (13.3) | |
Tumor grade | ||
Low grade | 22 (73.3) | 0.09 |
High grade | 8 (26.7) | |
Tumor stage | ||
Ta | 20 (66.6) | 0.02 |
T1 | 10 (33.3) |